BACKGROUND: Estimates of influenza vaccine effectiveness in elderly individuals are largely from observational studies, which are susceptible to bias. Instrumental variable (IV) methods control for overt and hidden biases in observational studies. METHODS: We used linked health administrative databases in Ontario to examine the association between influenza vaccination and all-cause mortality among community-dwelling individuals older than 65 years for 9 influenza seasons (2000-2001 to 2008-2009). We examined the composite of hospitalization for pneumonia and influenza and all-cause mortality as a secondary outcome. We used logistic regression modeling and IV analysis to remove the effect of selection bias. RESULTS: We included 12 621 806 person-influenza seasons of observation. Logistic regression produced adjusted odds ratios of 0.67 (95% CI, 0.62-0.72) for all-cause mortality during influenza seasons and 0.85 (0.83-0.86) during post-influenza seasons when influenza is not circulating, suggesting the presence of bias. In contrast, IV analysis yielded adjusted odds ratios of 0.94 (95% CI, 0.84-1.03) during influenza seasons and 1.13 (1.07-1.19) during post-influenza seasons. For the composite of hospitalization for pneumonia and influenza and death, logistic regression produced adjusted odds ratios of 0.74 (95% CI, 0.70-0.78) during influenza seasons and 0.88 (0.87-0.90) during post-influenza seasons, whereas IV analysis produced adjusted odds ratios of 0.86 (95% CI, 0.79-0.92) and 1.02 (0.97-1.06), respectively. CONCLUSIONS: Influenza vaccination is associated with reductions in the composite of hospitalizations for pneumonia and influenza and all-cause mortality during the influenza season but not mortality alone. Compared with standard modeling, IV analysis appears to produce less-biased estimates of vaccine effectiveness.
BACKGROUND: Estimates of influenza vaccine effectiveness in elderly individuals are largely from observational studies, which are susceptible to bias. Instrumental variable (IV) methods control for overt and hidden biases in observational studies. METHODS: We used linked health administrative databases in Ontario to examine the association between influenza vaccination and all-cause mortality among community-dwelling individuals older than 65 years for 9 influenza seasons (2000-2001 to 2008-2009). We examined the composite of hospitalization for pneumonia and influenza and all-cause mortality as a secondary outcome. We used logistic regression modeling and IV analysis to remove the effect of selection bias. RESULTS: We included 12 621 806 person-influenza seasons of observation. Logistic regression produced adjusted odds ratios of 0.67 (95% CI, 0.62-0.72) for all-cause mortality during influenza seasons and 0.85 (0.83-0.86) during post-influenza seasons when influenza is not circulating, suggesting the presence of bias. In contrast, IV analysis yielded adjusted odds ratios of 0.94 (95% CI, 0.84-1.03) during influenza seasons and 1.13 (1.07-1.19) during post-influenza seasons. For the composite of hospitalization for pneumonia and influenza and death, logistic regression produced adjusted odds ratios of 0.74 (95% CI, 0.70-0.78) during influenza seasons and 0.88 (0.87-0.90) during post-influenza seasons, whereas IV analysis produced adjusted odds ratios of 0.86 (95% CI, 0.79-0.92) and 1.02 (0.97-1.06), respectively. CONCLUSIONS: Influenza vaccination is associated with reductions in the composite of hospitalizations for pneumonia and influenza and all-cause mortality during the influenza season but not mortality alone. Compared with standard modeling, IV analysis appears to produce less-biased estimates of vaccine effectiveness.
Authors: Aurora Pop-Vicas; Momotazur Rahman; Pedro L Gozalo; Stefan Gravenstein; Vincent Mor Journal: J Am Geriatr Soc Date: 2015-08-17 Impact factor: 5.562
Authors: Carmen Arriola; Shikha Garg; Evan J Anderson; Patrician A Ryan; Andrea George; Shelley M Zansky; Nancy Bennett; Arthur Reingold; Marisa Bargsten; Lisa Miller; Kimberly Yousey-Hindes; Lilith Tatham; Susan R Bohm; Ruth Lynfield; Ann Thomas; Mary Lou Lindegren; William Schaffner; Alicia M Fry; Sandra S Chaves Journal: Clin Infect Dis Date: 2017-10-15 Impact factor: 9.079
Authors: Colin R Simpson; Nazir I Lone; Kim Kavanagh; Tanya Englishby; Chris Robertson; Jim McMenamin; Beatrix von Wissman; Eleftheria Vasileiou; Christopher C Butler; Lewis D Ritchie; Rory Gunson; Jürgen Schwarze; Aziz Sheikh Journal: Health Technol Assess Date: 2020-12 Impact factor: 4.014
Authors: John M Brooks; Yuexin Tang; Cole G Chapman; Elizabeth A Cook; Elizabeth A Chrischilles Journal: J Clin Epidemiol Date: 2013-08 Impact factor: 6.437
Authors: Giedre Gefenaite; Margot Tacken; Jens Bos; Irina Stirbu-Wagner; Joke C Korevaar; Ronald P Stolk; Bert Wolters; Marc Bijl; Maarten J Postma; Jan Wilschut; Kristin L Nichol; Eelko Hak Journal: PLoS One Date: 2013-06-20 Impact factor: 3.240
Authors: C King; J Beard; A C Crampin; A Costello; C Mwansambo; N A Cunliffe; R S Heyderman; N French; N Bar-Zeev Journal: Vaccine Date: 2015-07-30 Impact factor: 3.641
Authors: Salaheddin M Mahmud; Songul Bozat-Emre; Gregory Hammond; Lawrence Elliott; Paul Van Caeseele Journal: PLoS One Date: 2015-11-23 Impact factor: 3.240